The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis

Prostate Cancer, Version 1.2016

(2016) James L. Mohler et al.   Journal of the National Comprehensive Cancer Network

More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer

(2015) Firas Abdollah et al.   EUROPEAN UROLOGY

Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis

(2015) Takuya Koie et al.   International Journal of Clinical Oncology

Thromboembolic Complications in 3,544 Patients Undergoing Radical Prostatectomy with or without Lymph Node Dissection

(2015) Stavros I. Tyritzis et al.   JOURNAL OF UROLOGY

The role of extended pelvic lymphadenectomy with radical prostatectomy for high-risk prostate cancer

(2015) Andrew C. Harbin et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis

(2013) Kwang Hyun Kim et al.   BJU INTERNATIONAL

Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy

(2013) Nataniel H. Lester-Coll et al.   CANCER

Pelvic Lymph Node Dissection During Robot-assisted Radical Prostatectomy: Efficacy, Limitations, and Complications—A Systematic Review of the Literature

(2013) Guillaume Ploussard et al.   EUROPEAN UROLOGY

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

(2013) Axel Heidenreich et al.   EUROPEAN UROLOGY

Reply

(2013) Trinity J. Bivalacqua et al.   UROLOGY

Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

(2012) Steven Joniau et al.   EUROPEAN UROLOGY

WITHDRAWN: Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study

(2012) Jindong Ji et al.   JOURNAL OF SURGICAL RESEARCH

Safety and effectiveness of neoadjuvant luteinizing hormone-releasing hormone agonist plus low-dose estramustine phosphate in high-risk prostate cancer: a prospective single-arm study

(2012) T Koie et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Robot-assisted extended pelvic lymph node dissection (PLND) at the time of radical prostatectomy (RP): a video-based illustration of technique, results, and unmet patient selection needs

(2011) John W. Davis et al.   BJU INTERNATIONAL

Minimum incision endoscopic radical prostatectomy: Clinical and oncological outcomes at a single institute

(2011) T. Koie et al.   EJSO

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Therapeutic value of lymph node dissection at radical prostatectomy: a population-based case-cohort study

(2010) Diana R. Withrow et al.   BJU INTERNATIONAL

The Clavien-Dindo Classification of Surgical Complications

(2009) Pierre A. Clavien et al.   ANNALS OF SURGERY

Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Before Radical Prostatectomy for Patients With High Risk Localized Prostate Cancer

(2008) Kim N. Chi et al.   JOURNAL OF UROLOGY